Skip to main content

Pau Sarle Valles

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Pau Sarle Valles

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Projects

Advancing Parkinson's disease management: targeting autophagic-lysosomal dysfunction for innovative diagnostics and therapeutics

IP: Marta Martínez Vicente
Collaborators: José Antonio Arranz Amo, Mercedes Arrúe Gonzalo, Silvia Enriquez Calzada, Jorge Hernández Vara, Pau Sarle Valles, Eddie Pradas Gracia, Maria Camprodon Gomez, Laura Castillo Ribelles, Clara Carnicer Cáceres, Jordi Riera Heredia, Pablo Castillo Sánchez
Funding agency: Instituto de Salud Carlos III
Funding: 265000
Reference: PI24/00062
Duration: 01/01/2025 - 31/12/2027

Related news

The initiative seeks to raise awareness of the disease and promote the well-being of those affected, while fostering empathy and scientific vocations among young people.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Related professionals

Toni Soriano Colomé

Toni Soriano Colomé

Research technician
Cardiovascular Diseases
Read more
Jessica  Aguilera  Garcia

Jessica Aguilera Garcia

Predoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Sandra Maldonado  Moyano

Sandra Maldonado Moyano

Reconstructive Surgery of the Locomotor System
Read more
Alberto Roque Pérez

Alberto Roque Pérez

Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.